Medical Devices Companies By Enterprise Value
LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Current Valuation
| Current Valuation | Efficiency | Market Risk | Exp Return | ||||
|---|---|---|---|---|---|---|---|
| 1 | BBNX | Beta Bionics, Common | (0.30) | 4.68 | (1.38) | ||
| 2 | CBLL | CeriBell, | (0.12) | 3.67 | (0.43) | ||
| 3 | BDMD | Baird Medical Investment | 0.12 | 81.92 | 10.23 | ||
| 4 | SNWV | SANUWAVE Health, Common | 0.22 | 4.18 | 0.91 | ||
| 5 | NUVO | Holdco Nuvo Group | 0.11 | 105.92 | 11.79 | ||
| 6 | NAYA | NAYA Biosciences, | (0.23) | 8.72 | (1.99) | ||
| 7 | BSGM | BioSig Technologies, Common | (0.16) | 8.46 | (1.34) |
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents. Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.